Alembic Pharma secures INR 350 crore via allotment of NCDs
The company said it has also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs...aggregating to Rs 200 crore.
- Country:
- India
Drug firm Alembic Pharmaceuticals Friday said it has raised Rs 350 crore through allotment of non-convertible debentures (NCDs) on private placement basis.
"The NCD committee of Alembic Pharmaceuticals Ltd...has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs)... aggregating to Rs 150 crore under tranche I," Alembic Pharmaceuticals said in a regulatory filing.
The company said it has also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs...aggregating to Rs 200 crore.
Shares of Alembic Pharmaceuticals were trading 0.42 per cent lower at Rs 615 apiece on BSE.
Google News